Bit & Bridle

Equine Hyperkalemic Periodic Paralysis (HYPP)

Other Names

  • HYPP
  • Impressive Syndrome
  • Periodic Paralysis in Horses
  • Hyperkalaemic Periodic Paralysis

What is Equine Hyperkalemic Periodic Paralysis?

Equine Hyperkalemic Periodic Paralysis (HYPP) is an inherited muscle disorder caused by a defect in the sodium channels of skeletal muscle cells. The condition causes episodes of muscle weakness, trembling, and in severe cases, recumbency or collapse — often with simultaneous elevation of potassium levels in the blood (hyperkalaemia). Between episodes, affected horses may appear completely normal.

HYPP is strongly linked to one specific stallion: Impressive, a heavily muscled Quarter Horse born in 1969 who became enormously influential in halter horse breeding. The “Impressive” mutation was identified in 1992, and it is now estimated that over 100,000 horses worldwide carry the genetic defect — almost all descendants of Impressive through Quarter Horse, Paint, Palomino, and Appaloosa bloodlines.

The condition is autosomal dominant, meaning a single copy of the mutant gene is sufficient to cause the disease. Horses with two copies of the mutation (homozygous) are typically more severely affected than those with one copy (heterozygous). The American Quarter Horse Association (AQHA) has banned the registration of homozygous HYPP horses born after 2007.

Causes

HYPP is caused by a point mutation in the SCN4A gene, which encodes the alpha subunit of skeletal muscle sodium channels. This mutation causes the sodium channels to remain partially open at rest, leading to prolonged membrane depolarisation and abnormal muscle excitability.

Under normal circumstances, skeletal muscle sodium channels open briefly in response to a nerve signal, causing muscle contraction, then close. In HYPP horses, the defective channels do not close properly, causing uncontrolled muscle activity. Elevated blood potassium levels (often triggered by high-potassium feeds or stress) worsen the situation by further altering membrane potential and triggering episodes.

Key triggers for HYPP episodes include:

  • High-potassium feeds — including certain hays, lush pasture, molasses, and electrolyte supplements containing potassium
  • Fasting or irregular feeding schedules
  • Stress — transport, veterinary procedures, competition
  • Changes in exercise routine
  • General anaesthesia

Symptoms and Signs

HYPP episodes can range from subtle to life-threatening. Signs typically include:

  • Muscle trembling or fasciculations — particularly over the neck, shoulders, and hindquarters
  • Sweating without significant exercise
  • Weakness — affected horses may appear wobbly or uncoordinated
  • Yawning, stretching, or unusual posturing
  • Upper airway obstruction — the laryngeal muscles can be affected, causing abnormal respiratory noise or breathing difficulty
  • Dysphagia — difficulty swallowing
  • Recumbency (lying down and inability to rise) in severe episodes
  • Collapse in the most severe cases

Episodes typically last 15–60 minutes and resolve spontaneously in mild cases. The horse usually appears normal between episodes, though mild muscle trembling or sweating may be noticed at exercise. Some horses have daily episodes; others may go weeks or months without an obvious attack.

The characteristic heavily muscled appearance of horses bred in the Impressive lineage — known as “hyper-muscling” — is itself a phenotypic consequence of the HYPP mutation and associated breeding selection, not a separate trait.

Diagnosis

HYPP can be confirmed by genetic DNA testing, which is definitive and relatively inexpensive:

  • DNA testing: Hair root or blood samples tested for the SCN4A mutation. Results classify horses as H/H (homozygous affected), H/N (heterozygous affected), or N/N (normal, unaffected). This is the most reliable diagnostic method.
  • Blood potassium during an episode: Serum potassium is elevated during attacks — typically above 5.5 mEq/L. Normal equine potassium is 3.5–5.0 mEq/L.
  • Electromyography (EMG): May reveal abnormal spontaneous electrical activity in affected muscles, though this is not routinely performed.
  • Clinical presentation: In horses from known Impressive bloodlines, the characteristic episodic muscle weakness combined with elevated potassium during episodes is strongly suggestive.

Treatment

Management focuses on reducing episode frequency and severity through dietary control and, where necessary, medication:

  • Dietary management: The most important long-term intervention. Feed low-potassium feeds — timothy or oat hay rather than orchard grass or alfalfa. Avoid molasses-containing feeds, beet pulp with molasses, and high-potassium supplements. Ensure regular feeding — fasting increases episode risk.
  • During an acute episode:
    • Offer grain, corn syrup, or Karo syrup orally if the horse can swallow — carbohydrates stimulate insulin release, driving potassium into cells
    • Light exercise such as hand-walking if the horse can safely move
    • Acetazolamide (a carbonic anhydrase inhibitor) given orally — reduces serum potassium and is often effective within 30–60 minutes for mild to moderate episodes
  • IV treatment for severe episodes: Your vet may administer IV calcium gluconate (to stabilise cell membranes), IV sodium bicarbonate, or IV dextrose with insulin to rapidly reduce serum potassium in life-threatening episodes. Upper airway obstruction may require emergency tracheostomy.
  • Long-term medication: Acetazolamide given twice daily is effective for horses with frequent episodes that are not adequately controlled by diet alone.

Prevention

For owners of HYPP horses:

  • Feed consistently — never allow long periods without forage access
  • Use low-potassium hay; test hay for potassium content where possible (target below 1.5% potassium dry matter)
  • Avoid high-risk feeds listed above
  • Minimise stressful events where possible; prepare horses gradually for travel and competition
  • Inform your vet of the HYPP status before any anaesthetic procedure

For breeders: DNA test all horses from Impressive bloodlines before breeding. The AQHA and other registries require HYPP testing and restrict registration of homozygous horses. Breeding two H/N horses together should be avoided as 25% of foals will be H/H (severely affected).

Prognosis

With appropriate dietary management and medical treatment, many HYPP horses lead comfortable, productive lives. Heterozygous (H/N) horses with mild disease that respond well to dietary management and acetazolamide can compete and work at various levels. Homozygous (H/H) horses are typically more severely affected and harder to manage. Upper airway involvement, frequent severe episodes, or inadequate response to management carry a poorer prognosis. Some severely affected horses require euthanasia due to unmanageable episodes.

When to Call the Vet

Call your vet immediately if:

  • Your horse has an episode severe enough to cause recumbency or breathing difficulty
  • An episode does not resolve within 30–60 minutes
  • The horse cannot swallow or shows signs of upper airway obstruction
  • You have a heavily muscled Quarter Horse, Paint, or Appaloosa descendant of Impressive bloodlines that has never been tested

Frequently Asked Questions

Is HYPP the same as tying up?

No, though both involve muscle dysfunction. Exertional rhabdomyolysis (tying up) is typically triggered by exercise and involves muscle fibre breakdown, elevated CK and AST enzymes, and hindlimb stiffness. HYPP episodes occur at rest or with minimal activity, are caused by sodium channel dysfunction rather than muscle breakdown, and are associated with elevated potassium rather than muscle enzymes.

Can HYPP horses compete?

Many heterozygous HYPP horses compete successfully in various disciplines with appropriate management. Some breed registries and competition bodies have introduced rules around HYPP horses, particularly homozygous animals, so it is important to check the specific requirements for your discipline and registration body.

What is the “Impressive” horse?

Impressive was an American Quarter Horse halter horse born in 1969, celebrated for his exceptional muscular development. He won numerous championships and became one of the most widely used halter horse sires in history. His extraordinary musculature — now understood to be a consequence of the HYPP mutation — was considered highly desirable by breeders, leading to massive use of him and his descendants before the genetic basis of his condition was understood. See also: Quarter Horse breed information.

Does HYPP affect horses outside Quarter Horse breeds?

HYPP in horses is almost entirely restricted to descendants of the stallion Impressive, who was a Quarter Horse. Because Quarter Horse bloodlines have been introduced into Paint Horses, Palominos, and Appaloosas, HYPP is found across these breeds. It is extremely rare outside Impressive descendants and has not been documented as a naturally occurring condition in other breeds such as Thoroughbreds or Warmbloods.